menu
    • menu

    Company profile for Cenexi

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cenexi is dedicated to contract manufacturing and services to pharmaceutical industry.Cenexi galenical portfolio for manufacturing is :High-Potent : freeze dried, vials, tablets, hard gelatine capsules;Non High Potent : freeze dried, vials, sterile ampoules, tablets, hard gelatine capsules, sterile drops (ocular and auricular), nasal spray, syrups and suppositories.Cenexi Services portfolio concerns full and partial pharmaceut...
    Cenexi is dedicated to contract manufacturing and services to pharmaceutical industry.Cenexi galenical portfolio for manufacturing is :High-Potent : freeze dried, vials, tablets, hard gelatine capsules;Non High Potent : freeze dried, vials, sterile ampoules, tablets, hard gelatine capsules, sterile drops (ocular and auricular), nasal spray, syrups and suppositories.Cenexi Services portfolio concerns full and partial pharmaceutical development including dossier writing & stability studies.Cenexi aim is to put in place long term partnership with worldwide pharmaceutical companies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CenexiFrance Flag
    Country
    Country
    France
    Address
    Address
    52, rue Marcel et Jacques Gaucher 94120 Fontenay-sous-Bois France
    Telephone
    Telephone
    33 143 948 902
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cenexi.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Gland Pharma acquires French CDMO Cenexi for €120 million
    Gland Pharma acquires French CDMO Cenexi for €120 million

    29 Nov 2022

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/gland-pharma-acquires-french-cdmo-cenexi-for-120-million/articleshow/95858995.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

    ECONOMIC TIMES
    29 Nov 2022
    Share Share
    Humanigen and Cenexi Announce Collaboration to Manufacture Lenzilumab in France
    Humanigen and Cenexi Announce Collaboration to Manufacture Lenzilumab in France

    08 Feb 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220208006060/en

    BUSINESSWIRE
    08 Feb 2022
    Share Share
    OSE Immunotherapeutics Announces Manufacturing Agreement with Cenexi
    OSE Immunotherapeutics Announces Manufacturing Agreement with Cenexi

    30 Jun 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/06/30/2255286/0/en/OSE-Immunotherapeutics-Announces-Manufacturing-Agreement-with-Cenexi-for-Clinical-Batches-of-CoVepiT-OSE-s-Multi-Target-Second-Generation-COVID-19-Vaccine.html

    GLOBENEWSWIRE
    30 Jun 2021
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search